Misplaced Pages

Colextran: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Browse history interactively ← Previous editContent deleted Content addedVisual WikitextInline

Revision as of 01:35, 30 May 2023 editEntranced98 (talk \| contribs)Extended confirmed users, Pending changes reviewers, Rollbackers170,249 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper ← Previous edit		Latest revision as of 07:48, 16 December 2023 edit undoInternetArchiveBot (talk \| contribs)Bots, Pending changes reviewers5,379,189 edits Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5
Line 40:		Line 40:
	\| molecular_weight = 277.315		\| molecular_weight = 277.315
	}}		}}
	'''Colextran''' (]) is a ]. Chemically, it is an ] of ] and ].<ref>Drugs.com: </ref>		'''Colextran''' (]) is a ]. Chemically, it is an ] of ] and ].<ref>Drugs.com: {{Webarchive\|url=https://web.archive.org/web/20190818003226/https://www.drugs.com/international/colextran.html \|date=2019-08-18 }}</ref>

	==References==		==References==

Latest revision as of 07:48, 16 December 2023

Chemical compound Pharmaceutical compound

Colextran
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C10AC03 (WHO)
Identifiers
CAS Number	9015-73-0
ChemSpider	none
KEGG	D07744
CompTox Dashboard (EPA)	DTXSID40864168
ECHA InfoCard	100.132.944
Chemical and physical data
Formula	C₁₂ H₂₃ NO₆ X₂
Molar mass	277.315
(what is this?) (verify)

Colextran (INN) is a bile acid sequestrant. Chemically, it is an ether of dextran and diethylethanolamine.

References

Drugs.com: Colextran Archived 2019-08-18 at the Wayback Machine

v
t
e

Lipid-lowering agents (C10)

Cholesterol absorption inhibitors, NPC1L1	Ezetimibe Hyzetimibe SCH-48461
Bile acid sequestrants/resins (LDL)	Colesevelam Colestilan Colestipol Colestyramine Colextran Soluble fiber such as psyllium and glucomannan

Statins (HMG-CoA reductase, LDL)	Atorvastatin Cerivastatin Fluvastatin Lovastatin Mevastatin Pitavastatin Pravastatin Rosuvastatin Simvastatin
Niacin and derivatives (HDL and LDL)	Acipimox Aluminium nicotinate Niacin Niceritrol Nicofuranose Nicotinyl alcohol
MTTP inhibitors (VLDL)	Dirlotapide Lomitapide Mitratapide
ATP citrate lyase inhibitors (LDL)	Bempedoic acid
Thyromimetics (VLDL)	Dextrothyroxine Resmetirom

PPAR agonists (LDL)

Fibrates	Aluminium clofibrate Bezafibrate Choline fenofibrate Ciprofibrate Clinofibrate Clofibrate Clofibride Etofibrate Fenofibrate Gemfibrozil Nafenopin Pemafibrate Ronifibrate Simfibrate
Others	GW501516

CETP inhibitors (HDL)

PCSK9 inhibitors (LDL)

ANGPTL3 inhibitors (LDL/HDL)

Evinacumab

Combinations

Other

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

v
t
e